{"id":9515,"date":"2021-10-27T11:11:56","date_gmt":"2021-10-27T09:11:56","guid":{"rendered":"https:\/\/world-heart-federation.org\/?post_type=news&p=9515"},"modified":"2021-10-27T15:17:28","modified_gmt":"2021-10-27T13:17:28","slug":"taking-up-arms-against-the-flu","status":"publish","type":"news","link":"https:\/\/world-heart-federation.org\/news\/taking-up-arms-against-the-flu\/","title":{"rendered":"Taking up arms against the flu"},"content":{"rendered":"
Guest post: Professor Laurence Sperling, Katz Professor in Preventive Cardiology and Professor of Global Health, Founder of The Heart Disease Prevention Center at Emory University and Past-President of The American Society for Preventive Cardiology.<\/em><\/strong><\/p>\n The heart is not the first organ we think of during influenza (flu) season. Yet, although influenza impacts the respiratory system, it also increases the likelihood of cardiovascular events especially in those with a prior history of cardiovascular disease (CVD). While age and underlying health conditions affect our susceptibility or resistance to illness, the flu can strike anyone, creating new health problems or worsening the outcome for those with pre-existing conditions–it may even be fatal.<\/p>\n Influenza can pose a ten-fold risk of a heart attack and an eight-fold risk of stroke among otherwise healthy people a few days following viral infection. The flu can trigger the body\u2019s immune response leading to plaque rupture and increased risk of vascular blood clots. Fighting the influenza virus can put stress on the body, especially when there is an already compromised heart. Those over 65 years of age, those living with underlying illnesses, and pregnant women are in particularly high-risk groups.<\/p>\n Influenza vaccination helps us generate the antibodies needed to stave off severe illness and complications. Every year, specialists study the data and evolution of the different viral strains. Vaccines are tailored by analysing the types of flu that are likely to spread as well as by examining efficacy of vaccines in previous flu seasons.<\/p>\n The health benefits and cost savings of influenza vaccine uptake have been demonstrated. In middle-aged people with arterial disease, the flu vaccine could lower the risk of a heart\u00a0attack by as much as 45 per cent;<\/a> in European Union countries, flu vaccination can potentially save<\/a> up to 37,200 lives and \u20ac332,000 million every season.<\/p>\n <\/p>\n Reasons and remedies<\/strong><\/p>\n Vaccine equity is a key approach to collective protection from the flu. However, barriers<\/a> including social demographics, perceptions of personal risk, as well as healthcare access, cost and infrastructure need to be addressed. Vaccination rates among people living with heart disease vary across age, gender and ethnicity.<\/a><\/p>\n